Evaluating the feasibility of a pharmacist-guided patient-driven intervention to improve blood pressure control in patients with CKD

Pilot and Feasibility Studies
Charles HopleyDiana Jalal

Abstract

Self-titration of blood pressure (BP) medications and lifestyle modifications are effective and safe strategies to lower BP. We assessed the feasibility of implementing a pharmacist-guided, patient-driven self-titration protocol and standardized dietary counseling to improve BP in the chronic kidney disease (CKD) clinic. Adult patients seen in the CKD clinic were identified via registry screening. Inclusion criteria were as follows: a diagnosis of hypertension, average of the last 3 office BP > 150/90 mmHg, and prescribed 3 or fewer BP medications. Patients with severe hypertension were excluded. BP goals were established and patients were referred to the clinical pharmacist who provided them a BP cuff, a BP medication titration plan (based on home BP monitoring), and dietary education. The following outcomes were evaluated: appeal of the program to patients identified by the registry, patient adherence to the protocol and 6-month office BP, and provider attitudes and acceptance of the protocol. Seventeen patients enrolled in the pilot, the majority recruited via clinic schedule screening. Eleven of the 17 patients completed a 6-month office follow-up visit. Three of the 11 patients met their pre-specified office BP goal. There...Continue Reading

References

Aug 31, 2004·Journal of General Internal Medicine·Philip B MellenDenise E Bonds
Mar 9, 2006·The Journal of Clinical Hypertension·Gbenga Ogedegbe, Antoinette Schoenthaler
Feb 3, 2007·The Journal of Clinical Hypertension·Gail ArderyYoonsang Kim
Mar 11, 2008·Patient Education and Counseling·Robert A Bell, Richard L Kravitz
Apr 2, 2008·The New England Journal of Medicine·Nigel S BeckettUNKNOWN HYVET Study Group
Apr 11, 2008·The Journal of Clinical Hypertension·Barry L CarterArthur J Hartz
Jul 22, 2008·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Auke H BrantsmaUNKNOWN PREVEND Study Group
Jan 9, 2009·The Journal of Clinical Hypertension·Thomas G PickeringUNKNOWN American Society of Hypertension Writing Group
Mar 17, 2010·The New England Journal of Medicine·William C CushmanFaramarz Ismail-Beigi
Oct 13, 2010·Archives of Internal Medicine·Cynthia A WeberBarry L Carter
Jul 4, 2013·JAMA : the Journal of the American Medical Association·Karen L MargolisNicole K Trower
Apr 1, 2014·JAMA : the Journal of the American Medical Association·Ann Marie Navar-BogganEric D Peterson
Nov 7, 2014·Journal of General Internal Medicine·Heather M JohnsonMaureen A Smith
Apr 18, 2015·Pharmacotherapy·UNKNOWN American College of Clinical PharmacyScot Walker
Nov 5, 2015·Lancet·Patrick RossignolUNKNOWN Cardiovascular and Renal Clinical Trialists (F-CRIN INI-CRCT) network
Nov 10, 2015·The New England Journal of Medicine·UNKNOWN SPRINT Research GroupWalter T Ambrosius
Jan 13, 2016·Annals of Family Medicine·James E SharmanMark R Nelson
Jan 20, 2018·Current Hypertension Reports·Korey A KenneltyBarry L Carter

❮ Previous
Next ❯

Software Mentioned

My
Epic
Survey Monkey
HealthyPlanet
My Health Connection
SAS

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.